Myocardial fibrosis in severe aortic stenosis

Current Cardiology Reports

Volumn 12, Issue 3, 2010, Pages 196-198

  Tsang, Wendy ^a   Lang, Roberto M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; GADOLINIUM; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

AORTA STENOSIS; AORTA VALVE REPLACEMENT; CONTRAST ENHANCEMENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HUMAN; M MODE ECHOCARDIOGRAPHY; MORTALITY; NON INVASIVE MEASUREMENT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME;

EID: 77956393108     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0097-6     Document Type: Note

References (3)

1. Lund O: Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Circulation 1990, 82:124-130.
2. Hachicha Z, Dumesnil JG, Bogaty P: Paradoxical low-flow, lowgradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007, 115:2856-2864.
3. Strotmann JM, Lengenfelder B, Blondelot J, et al.: Functional differences of left ventricular hypertophy induced by either arterial hypertension of aortic valve stenosis. Am J Cardiol 2008, 101:1493-1497.